Skip to search.
 TSX Down 0.40% TSX Ventures Up 0.34%

Dyax Corp. (DYAX)

-NasdaqGM
16.20 Down 0.05(0.31%) 4:00PM EDT
|After Hours : 16.20 0.00 (0.00%) 4:37PM EDT
Add to Portfolio
Prev Close:16.25
Open:16.16
Bid:12.10 x 400
Ask:N/A
1y Target Est:17.06
Beta:0.51
Earnings Date:Apr 28 - May 4 (Est.)
Day's Range:15.84 - 16.62
52wk Range:6.05 - 18.07
Volume:1,179,557
Avg Vol (3m):930,720
Market Cap:2.22B
P/E (ttm):N/A
EPS (ttm):-0.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DYAXDown 0.31%2.22B
SHPGDown 0.43%46.66B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):27.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.19
Quarterly EPS Est (Mar-15) :-0.05
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-4.81

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback